Clene (CLNN) director granted 2,438 stock options at $7.30

Clene Inc. (CLNN) reported a director equity award on Form 4.

Rhea-AI Filing Summary

Clene Inc. (CLNN) reported a director equity award on Form 4. On November 13, 2025, the director received a stock option covering 2,438 shares of common stock at an exercise price of $7.30 per share under the Clene Inc. Amended 2020 Stock Plan. The option vests immediately upon grant and carries an expiration date of November 12, 2035.

The filing classifies the transaction as an acquisition of derivative securities and lists direct ownership following the grant.

Insights

Executive compensation analyst

Routine director stock option grant with immediate vesting.

Clene Inc. reported a director’s stock option grant for 2,438 shares at an exercise price of $7.30 on November 13, 2025. The award was granted under the company’s Amended 2020 Stock Plan and vests immediately, indicating the recipient can exercise at any time before expiry.

The option expires on November 12, 2035. As a standard equity compensation event, it does not by itself signal operational changes. Any future impact depends on whether and when the option is exercised.

Insider Trade Summary

Grant/Award: 2,438 shares

Grant/Award 1 txn

Insider Gay Jonathon

Role Director

Type	Security	Shares	Price	Value
Grant/Award	stock option	2,438	$0.00	$0.00

Holdings After Transaction: stock option — 2,438 contracts (Direct)

Footnotes (1)

1. F1. This option was granted on November 13, 2025 as an option for 2,438 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $7.30 per share. The options vest immediately upon grant.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Clene (CLNN) disclose on this Form 4?

A director received a stock option covering 2,438 shares at an exercise price of $7.30 per share.

When was the Clene (CLNN) option granted and when does it expire?

The option was granted on November 13, 2025 and expires on November 12, 2035.

How does the vesting work for this Clene (CLNN) option?

The option vests immediately upon grant, allowing exercise any time before expiration.

Under which plan was the Clene (CLNN) option issued?

It was issued under the Clene Inc. Amended 2020 Stock Plan.

What ownership form is indicated after the transaction?

The filing shows direct ownership following the reported transaction.

What type of security was reported on Clene’s (CLNN) Form 4?

A derivative security—a stock option—covering shares of common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/14/2025 - 04:47 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gay Jonathon

(Last) (First) (Middle)

6550 SOUTH MILLROCK DRIVE

SUITE G50

(Street)

SALT LAKE CITY UT 84121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
stock option	$7.3	11/13/2025		A		2,438		(1)	11/12/2035	common stock	2,438	$0	2,438	D

Explanation of Responses:

1. This option was granted on November 13, 2025 as an option for 2,438 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $7.30 per share. The options vest immediately upon grant.

	/s/ Jerome T. Miraglia POA	11/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.